Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.414 USD | -0.24% | +2.02% | -45.32% |
04-25 | Soligenix Extends Patent Protection for Its Filovirus Vaccine Platform to the United Kingdom and South Africa | CI |
04-15 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Sales 2024 * | 800K 63.72M | Sales 2025 * | 900K 71.68M | Capitalization | 5.91M 471M |
---|---|---|---|---|---|
Net income 2024 * | -8M -637M | Net income 2025 * | -9M -717M | EV / Sales 2024 * | 7.39 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.57 x |
P/E ratio 2024 * |
-0.66
x | P/E ratio 2025 * |
-0.73
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.93% |
1 day | -0.24% | ||
1 week | +2.02% | ||
Current month | -31.00% | ||
1 month | -31.00% | ||
3 months | -35.31% | ||
6 months | -15.84% | ||
Current year | -45.32% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 31/07/06 | |
Jonathan Guarino
DFI | Director of Finance/CFO | 51 | 10/09/19 |
Richard Straube
CTO | Chief Tech/Sci/R&D Officer | 72 | 05/01/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 31/07/06 | |
Gregg Lapointe
BRD | Director/Board Member | 65 | 28/02/09 |
Robert Rubin
BRD | Director/Board Member | 78 | 30/09/09 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 0.414 | -0.24% | 119,018 |
26/04/24 | 0.415 | -2.81% | 269,354 |
25/04/24 | 0.427 | +11.49% | 684,696 |
24/04/24 | 0.383 | -4.25% | 497,507 |
23/04/24 | 0.4 | -1.43% | 448,982 |
Delayed Quote Nasdaq, April 29, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.32% | 5.91M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- SNGX Stock